Name | (S)-(-)-3,5-dichloro-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamide L-(+)-tartrate |
---|---|
Synonyms |
(S)-2-[(3,5-dichloro-6-methoxy-2-hydroxybenzamido)methyl]-1-ethylpyrrolidine L-tartrate
raclopride tartarate raclopride tartrate (S)-2-[(3,5-dichloro-6-methoxy-2-hydroxybenzamido)methyl]-1-ethylpyrrolidine L-tartrate S(-)-RACLOPRIDE (+)-TARTRATE SALT |
Description | Raclopride tartrate is a selective dopamine D2/D3 receptor antagonist with potential antipsychotic effects. Raclopride tartrate binds to D2 and D3 receptors with Kis of 1.8 nM and 3.5 nM, respectively[1][2]. |
---|---|
Related Catalog | |
Target |
D2 Receptor:1.8 nM (Ki) D3 Receptor:3.5 nM (Ki) D4 Receptor:2400 nM (Ki) D1 Receptor:18000 nM (Ki) |
In Vivo | Raclopride tartrate (0.1, 0.3, or 0.6 mg/kg; IP; 30 min; albino male mice of the OF1 strain) significantly reduces time allocated to attack behavior[2]. |
References |
[1]. Seeman P, et al. Dopamine receptor pharmacology. Trends Pharmacol Sci. 1994;15(7):264-270. |
Molecular Formula | C19H26Cl2N2O9 |
---|---|
Molecular Weight | 497.32400 |
Exact Mass | 496.10200 |
PSA | 176.86000 |
LogP | 1.12790 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
RTECS | CV3465000 |